BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 25557532)

  • 1. Prevalence of parathyroid carcinoma in 348 patients with multiple endocrine neoplasia type 1 - case report and review of the literature.
    Singh Ospina N; Sebo TJ; Thompson GB; Clarke BL; Young WF
    Clin Endocrinol (Oxf); 2016 Feb; 84(2):244-249. PubMed ID: 25557532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of Parathyroid Carcinoma and Atypical Parathyroid Neoplasms in 153 Patients With Multiple Endocrine Neoplasia Type 1: Case Series and Literature Review.
    Song A; Yang Y; Liu S; Nie M; Jiang Y; Li M; Xia W; Wang O; Xing X
    Front Endocrinol (Lausanne); 2020; 11():557050. PubMed ID: 33101196
    [No Abstract]   [Full Text] [Related]  

  • 3. Parathyroid carcinoma in multiple endocrine neoplasm type 1 syndrome: case report and systematic literature review.
    Di Meo G; Sgaramella LI; Ferraro V; Prete FP; Gurrado A; Testini M
    Clin Exp Med; 2018 Nov; 18(4):585-593. PubMed ID: 29922966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple endocrine neoplasia type 1 syndrome: single centre experience from western India.
    Goroshi M; Bandgar T; Lila AR; Jadhav SS; Khare S; Shrikhande SV; Uchino S; Dalvi AN; Shah NS
    Fam Cancer; 2016 Oct; 15(4):617-24. PubMed ID: 26905068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parathyroid carcinoma in multiple endocrine neoplasia type 1 (MEN1) syndrome: two case reports of an unrecognised entity.
    Agha A; Carpenter R; Bhattacharya S; Edmonson SJ; Carlsen E; Monson JP
    J Endocrinol Invest; 2007 Feb; 30(2):145-9. PubMed ID: 17392605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of percutaneous parathyroid ethanol ablation in patients with recurrent primary hyperparathyroidism and multiple endocrine neoplasia type 1.
    Singh Ospina N; Thompson GB; Lee RA; Reading CC; Young WF
    J Clin Endocrinol Metab; 2015 Jan; 100(1):E87-90. PubMed ID: 25337928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of treatment with depot somatostatin analogue octreotide on primary hyperparathyroidism (PHP) in multiple endocrine neoplasia type 1 (MEN1) patients.
    Faggiano A; Tavares LB; Tauchmanova L; Milone F; Mansueto G; Ramundo V; De Caro ML; Lombardi G; De Rosa G; Colao A
    Clin Endocrinol (Oxf); 2008 Nov; 69(5):756-62. PubMed ID: 18485119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystic parathyroid glands in MEN1: A rare entity?
    Cavalli T; Giudici F; Nesi G; Amorosi A; Santi R; Brandi ML; Tonelli F
    Fam Cancer; 2017 Apr; 16(2):249-256. PubMed ID: 27766445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of multiple endocrine neoplasia type 1 in patients with apparent sporadic primary hyperparathyroidism.
    Yip L; Ogilvie JB; Challinor SM; Salata RA; Thull DL; Yim JH; Carty SE
    Surgery; 2008 Dec; 144(6):1002-6; discussion 1006-7. PubMed ID: 19041010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and treatment of multiple endocrine neoplasia type 1 (MEN1).
    Gaztambide S; Vazquez F; Castaño L
    Minerva Endocrinol; 2013 Mar; 38(1):17-28. PubMed ID: 23435440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Somatic mutations of the multiple endocrine neoplasia type 1 (MEN1) gene in patients with sporadic, nonfamilial primary hyperparathyroidism.
    Sato K; Yamazaki K; Zhu H; Kanbe M; Iihara M; Wada Y; Tanaka R; Okamoto T; Ito Y; Obara T
    Surgery; 2000 Mar; 127(3):337-41. PubMed ID: 10715991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary hyperparathyroidism: can parathyroid carcinoma be anticipated on clinical and biochemical grounds? Report of nine cases and review of the literature.
    Robert JH; Trombetti A; Garcia A; Pache JC; Herrmann F; Spiliopoulos A; Rizzoli R
    Ann Surg Oncol; 2005 Jul; 12(7):526-32. PubMed ID: 15889214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational and large deletion study of genes implicated in hereditary forms of primary hyperparathyroidism and correlation with clinical features.
    Pardi E; Borsari S; Saponaro F; Bogazzi F; Urbani C; Mariotti S; Pigliaru F; Satta C; Pani F; Materazzi G; Miccoli P; Grantaliano L; Marcocci C; Cetani F
    PLoS One; 2017; 12(10):e0186485. PubMed ID: 29036195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of multiple endocrine neoplasia type 1 in young patients with apparently sporadic primary hyperparathyroidism or pancreaticoduodenal endocrine tumours.
    Langer P; Wild A; Hall A; Celik I; Rothmund M; Bartsch DK
    Br J Surg; 2003 Dec; 90(12):1599-603. PubMed ID: 14648742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple endocrine neoplasia type 1: clinical and genetic features of the hereditary endocrine neoplasias.
    Marx SJ; Agarwal SK; Kester MB; Heppner C; Kim YS; Skarulis MC; James LA; Goldsmith PK; Saggar SK; Park SY; Spiegel AM; Burns AL; Debelenko LV; Zhuang Z; Lubensky IA; Liotta LA; Emmert-Buck MR; Guru SC; Manickam P; Crabtree J; Erdos MR; Collins FS; Chandrasekharappa SC
    Recent Prog Horm Res; 1999; 54():397-438; discussion 438-9. PubMed ID: 10548885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of cinacalcet hydrochloride in clinical management of primary hyperparathyroidism in multiple endocrine neoplasia type 1.
    Del Prete M; Marotta V; Ramundo V; Marciello F; Di Sarno A; Esposito R; Carratù AC; De Luca Di Roseto C; Di Somma C; Colao A; Faggiano A
    Minerva Endocrinol; 2013 Dec; 38(4):389-94. PubMed ID: 24285106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sporadic and MEN1-related primary hyperparathyroidism: differences in clinical expression and severity.
    Eller-Vainicher C; Chiodini I; Battista C; Viti R; Mascia ML; Massironi S; Peracchi M; D'Agruma L; Minisola S; Corbetta S; Cole DE; Spada A; Scillitani A
    J Bone Miner Res; 2009 Aug; 24(8):1404-10. PubMed ID: 19309299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple endocrine neoplasia type 1 (MEN1): its manifestations and effect of genetic screening on clinical outcome.
    Pieterman CR; Schreinemakers JM; Koppeschaar HP; Vriens MR; Rinkes IH; Zonnenberg BA; van der Luijt RB; Valk GD
    Clin Endocrinol (Oxf); 2009 Apr; 70(4):575-81. PubMed ID: 18616711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A patient with MEN1-associated hyperparathyroidism, responsive to cinacalcet.
    Falchetti A; Cilotti A; Vaggelli L; Masi L; Amedei A; Cioppi F; Tonelli F; Brandi ML
    Nat Clin Pract Endocrinol Metab; 2008 Jun; 4(6):351-7. PubMed ID: 18414463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MEN1 gene mutations in Hungarian patients with multiple endocrine neoplasia type 1.
    Balogh K; Hunyady L; Patocs A; Gergics P; Valkusz Z; Toth M; Racz K
    Clin Endocrinol (Oxf); 2007 Nov; 67(5):727-34. PubMed ID: 17953629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.